Stock

ASP Isotopes Shares Tumble on Fuzzy Panda Research Report

On Tuesday, shares of ASP Isotopes (ASPI) plummeted by 20% following a critical report from Fuzzy Panda Research. The report alleges that ASPI is utilizing outdated laser enrichment technology and is connected to individuals previously charged with securities fraud.

Fuzzy Panda Research claims that ASPI is masquerading as a new, innovative Uranium enrichment company while in reality, it is leveraging old and uneconomic technology. The report cites conversations with former executives from customers and competitors who have deemed ASPI’s technology virtually worthless. It further states that ASPI’s technology was once considered for acquisition by Centrus, but was rejected as it was not valued even at $2 million.

The report also mentions an array of concerns, including ASPI’s lack of patents, with the company claiming that patents would be detrimental and that their process is a trade secret. Additionally, it highlights the company’s questionable history, noting that it was incorporated in September 2021 and funded shortly after by a shell company with connections the individuals previously charged with securities fraud.

The investigation by Fuzzy Panda Research could not locate multiple ASPI subsidiaries at their registered addresses in South Africa. Furthermore, the report states that ASPI’s AVLIS technology, which involves the laser enrichment of uranium, has been scrapped by twenty governments after decades of research due to its lack of economic viability.

Experts have also expressed doubts about ASPI’s ability to obtain an NRC license to enrich Uranium, a process that could take up to 15 years. They have also contested the company’s cost estimates for building facilities, suggesting that the actual costs could run into the billions, as opposed to ASPI’s claim of less than $10 million.

The report concludes by asserting that ASP Isotopes might be the most egregious case yet of a paid stock promotion based on outdated technology, with a history of government research indicating that the technology is commercially nonviable.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

You May Also Like

Editor's Pick

Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

Economy

LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

Editor's Pick

Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

Latest News

Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 beneficialinvestmentnow.com

Exit mobile version